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100Objective:An increasing number of elderly patients are referred for pulmonary endarterectomy. The distinction
between operable and inoperable lesions has been challenged over time. Hence, we developed alternative car-
diopulmonary bypass management and cerebral protection strategies to obtain satisfactory surgical results ac-
cording to the changing patient features.
Methods: From April 1994 to March 2011, 347 pulmonary endarterectomies were performed at our center. We
began with the technique championed by the San Diego Group, adopting a single period of deep hypothermic
circulatory arrest for each side (group A). Since 2003, we began to perform short periods of intermittent deep
hypothermic circulatory arrest followed by periods of reperfusion (group B). We then adopted moderate, instead
of deep, hypothermia (group C). Finally, we modified our technique further performing shorter (5–7-minute)
periods of circulatory arrest (group D).
Results: The hemodynamic results after surgery were excellent in all 4 groups. The patients’ age increased sig-
nificantly. A trend toward an increase in the number of Jamieson type 3 lesions was observed. Associated with
our protocol changes, we observed better postoperative respiratory function, a reduction in the length of mechan-
ical ventilation and postoperative infections, and a remarkable improvement in uneventful postoperative
courses. Despite the increased total circulatory arrest time, a trend toward a reduction in the incidence of tran-
sient neurologic events was observed, and operative mortality was not affected.
Conclusions: In our experience, our alternative strategy resulted in a better combination of surgical accuracy
and cerebral protection and improved outcomes. (J Thorac Cardiovasc Surg 2012;144:100-7)Chronic thromboembolic pulmonary hypertension (CTEPH)
is a progressive disease due to the incomplete resolution of
pulmonary emboli, leading to right heart failure, with
a poor survival if left untreated. Despite the improved prog-
nosis with the introduction of specific medical treatment,1,2
pulmonary endarterectomy (PEA) is the only curative
therapy1-9 able to significantly improve the normally poor
prognosis.10 Even if appropriatemedical therapy is promptly
started, CTEPH is estimated to occur in approximately 0.5%
to 3.8% of patients who survive an acute episode of pulmo-
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The Journal of Thoracic and Cardiovascular Surgmuch greater,13 because small pulmonary emboli would
not be noticed unless many of them were showered into
the pulmonary circulation at once or within a certain period.
Hence, the epidemiology of CTEPH remains uncertain. Al-
though CTEPH is currently gaining the interest of a large
number of physicians and is increasingly being diagnosed,
underdiagnosis and late diagnosis remain the main issues.3
Surgery is indicated as soon as it has been diagnosed, before
the typical arteriopathy develops in both obstructed and non-
obstructed branches.2,14-16 PEA avoids the onset of the
described vascular remodeling, which is responsible for
the progressive worsening of CTEPH and the development
of a reactive component of pulmonary hypertension, not
directly curable by surgery.
Because no well-defined criteria are available to discrim-
inate proximal from distal obstructive lesions, a patient
should not be considered inoperable unless the case has
been reviewed by an experienced surgeon.2,3,16 According
to recent guidelines, a center can be considered to have
sufficient expertise if the number of PEAs performed is at
least 20 annually, with a mortality rate less than 10%.16 Be-
cause advanced techniques that enable dissection at subseg-
mental level have been developed, no embolic obstruction
is inaccessible, according to the Jamieson operativeery c July 2012
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
cNIRS ¼ cerebral near-infrared
spectroscopy
CTEPH ¼ chronic thromboembolic
pulmonary hypertension
HCA ¼ hypothermic circulatory arrest
J3 ¼ Jamieson type 3
LMV ¼ length of mechanical ventilation
PaO2/FiO2 6h ¼ partial pressure of oxygen in
arterial blood/fraction of inspired
oxygen 6 hours after admission to
intensive care unit
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Dclassification of CTEPH lesions.17 Thus, no grades of right
ventricular failure or levels of pulmonary vascular resis-
tance (PVR) contraindicate PEA.18,19 However, the
prognosis worsens with greater preoperative pulmonary
pressure and greater postoperative PVR.3,19,20
The surgical technique was largely developed by Jamie-
son.7 The complete removal of all thromboembolic mate-
rials is the key factor for a satisfactory outcome. To
achieve a completely bloodless surgical field, deep hypo-
thermic circulatory arrest (HCA) with aortic crossclamping
has been promoted as the strategy of choice and is still used
in the vast majority of centers performing PEAworldwide.3
PEA is still thought to be a very invasive surgery because of
the deep HCA required. Alternative cerebral protection
strategies have recently been proposed, especially concern-
ing PEA in the elderly, causing intense debate on the need
for deep HCA.21,22 At our center, we started in 1994 to
adopt the San Diego technique based on deep HCA,
except for leaving the aorta unclamped. As we gained
experience, we changed our cardiopulmonary bypass
(CPB) management further, adapting it to our evolving
learning curve, to minimize the burden of HCA. In the
present study, we analyzed the postoperative outcomes
according to the different strategies used.
METHODS
Patient Selection
From April 1994 to March 2011, 347 consecutive patients diagnosed
with CTEPH underwent PEA at our center. From 1994 onward, a prospec-
tive dedicated database, approved by the institutional review board, re-
corded the patients’ information. All patients provided informed consent.
Except for urgent or emergency operations, all CTEPH patients admitted
to our center underwent a complete diagnostic workup, according to our
published standardized protocol.23,24 The operability assessment was
performed by the same surgeon. A permanent inferior vena cava filter
was usually placed the day before surgery, unless contraindicated.
At our center, the only contraindication to PEA is underlying severe pa-
renchymal lung disease. Some investigators also consider the severity ofThe Journal of Thoracic and Cahemodynamic impairment, underlying major comorbidities, and patient
age.2-6,18,19 In our experience, we have never excluded any patient from
surgery on the basis of only age and preoperative conditions.
Patient referrals increased substantially over the years, and we became
more confident with the procedure. During 2004, 54 patients were referred
to our center for a surgical evaluation. A CTEPH diagnosis was confirmed
in 34 patients (63%), and the disease was deemed operable in 25, for an
operability rate of 74%. During 2010, we evaluated 108 patients, and the
diagnostic accuracy for CTEPH of the referring centers had increased to
76% (82/108 patients). Owing to our learning curve, CTEPH was deemed
operable in 73 patients. Thus, operability rate increased from 74% to 89%
(73/82). This resulted in a significant increase in PEAs performed each year
(Figure 1).
Surgical Technique
At our center, the surgical approach is according to the published sur-
gical technique,7 except for some technical details. The right atrium is
explored only if any atrial septal defect or thrombosis of the right heart
chambers is demonstrated during the diagnostic workup or by intraoper-
ative transesophageal echocardiography. The aorta is left unclamped
to avoid excessive manipulation of potential atherosclerotic plaques.
Myocardial protection is achieved without cardioplegia administration,
exclusively by hypothermia, with the left ventricle vented, even in the
presence of any degree of aortic regurgitation. The left ventricular vent
is placed after hypothermic ventricular fibrillation has occurred. An elec-
tric 2-lead cardiac fibrillator is placed when fibrillation does not occur de-
spite hypothermic perfusion. In ideal conditions, PEA can generally be
extended even toward the fourth and fifth order of arterial bifurcation.
The operation must always be performed bilaterally, because sometimes
the imaging tools can fail to detect partially obstructed or recanalized ar-
teries or intraluminal webs, which are almost regularly perfused by con-
trast agent. Once PEA is completed, the left ventricular vent is clamped
and bronchoscopy is performed to assess the absence of airway bleeding.
At the end of the operation, the pericardium is closed to reduce the de-
velopment of adhesions and promote better postoperative right ventricu-
lar function.
The following associated cardiac procedures were performed: 22 coro-
nary artery bypass grafts, 14 atrial septal defect repairs, and 2 aortic valve
replacements.
CPB Management
Our cerebral protection strategy has changed over time (Table 1). At the
beginning of our experience, we used to perform a single period of deep
HCA for each side (group A, 83 patients). In 2003, we performed a PEA
reoperation in a 80-year-old male patient. Five sessions of deep HCA of
20minutes and one of 15minutes were necessary. The hemodynamic result
after PEAwas excellent; however, the patient died of massive intestinal is-
chemia, probably as a complication of the long HCA period on his intesti-
nal microcirculation with a reduced flow reserve. Since then, we changed
our CPB management to reduce the burden of HCA, especially in the
elderly. Hence, we started to perform shorter (10–15-minute) periods of in-
termittent deep HCA followed by short (5-minute) periods of reperfu-
sion. We used cerebral near-infrared spectroscopy (cNIRS) to determine
the length of each reperfusion period (group B, 70 patients). Given evi-
dence that we could safely prolong the total HCA time, we started to thor-
oughly explore the segmental branches found to be patent on preoperative
examination. In some patients, wewere able to find and remove unexpected
lesions, such as recanalized thrombi and webs. To further reduce the surgi-
cal invasiveness, we combined intermittent periods of HCAwith moderate,
instead of deep, hypothermia (group C, 91 patients). The repeated interrup-
tions during PEA for reperfusion did not cause any significant loss of time
and did not represent a problem for the surgeon. Therefore, we modified
our technique further, performing even shorter (5–7-minute) periods of
moderate HCA (group D, 103 patients).rdiovascular Surgery c Volume 144, Number 1 101
FIGURE 1. Pulmonary endarterectomies (PEAs) performed by year and group.
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All the patients were monitored according to our protocol, including ra-
dial and femoral arterial lines for blood pressure, a Swan-Ganz catheter,
rectal and esophageal temperature probes, electrocardiography, pulse oxi-
metry, expired end-tidal carbon dioxide, transesophageal echocardiogra-
phy, and electroencephalography. cNIRS monitoring was adopted for
group B onward. Once CPB has been established, the patient’s systemic
temperature is cooled and hemodilution performed until the hemoglobin
reaches 7 g/dL. In addition, a cooling helmet is placed. When the target
temperature is reached, thiopental is administered until the electroenceph-
alogram becomes isoelectric. The bilateral cNIRS values are noted as the
baseline and compared during the circulatory arrests. Particular attention
must be paid to both the rate of the cNIRS decrease during HCA and the
rate of the cNIRS increase during reperfusion. Norepinephrine and dobut-
amine (or epinephrine) are routinely administered to assist with weaning
from CPB by improving the systemic perfusion pressure, including the cor-
onary blood flow. Inhaled nitric oxide is generally administered to improve
right ventricular function, especially if the PVR is not yet back to normal.
Early Postoperative Management
After PEA, the cardiac output is generally high, owing to the remarkable
unloading of the hypertrophic right ventricle, and can lead to lung reperfu-
sion edema. Hence, inotropes and inhaled nitric oxide are rapidly discon-
tinued, vasopressors agents are continued for a few days, and vigorous
diuresis is achieved to obtain a negative fluid balance. Protective ventilation
(high positive end-expiratory pressure and low tidal volume) is preferred to
prevent both lung reperfusion edema and ventilation-induced lung injury.
Extubation is performed as soon as possible, switching to helmet continu-
ous positive airway pressure ventilation for a few days. Vancomycin andTABLE 1. Study population by group according to cardiopulmonary bypa
Group CPB management
A Single 20-min HCA for each PEA side
B Intermittent 10–15-min HCA interrupted by reperf
C Intermittent 10–15-min HCA interrupted by reperf
D Intermittent 7-min HCA interrupted by reperfusio
CPB, Cardiopulmonary bypass; HCA, hypothermic circulatory arrest; PEA, pulmonary en
and anesthesia management were the same for all groups.
102 The Journal of Thoracic and Cardiovascular Surgceftazidime are routinely administered, unless other antibiotics are needed
according to the antibiogram.
Statistical Analysis
Our research was a retrospective case-cohort study with noncontem-
poraneous cohorts. The patient characteristics are reported as counts and
percentages, if categorical, and as the mean standard deviation or median
and 25th to 75th percentiles, if continuous. The variables were compared
among the 4 different operative protocols using the Fisher exact test and
analysis of variance (either parametric or nonparametric, eg, the Kruskal-
Wallis test) if continuous. The paired Student t-test was used to compare
the preoperative and postoperative values of the mean pulmonary arterial
pressure and PVR.
The association between the operative protocol and outcome was as-
sessed using generalized linear regression models (with either identity or
logistic link). Furthermore, the independent role of CPB management on
the operative outcome was controlled in a multivariate model for other po-
tential predictors of outcome (identified a priori, from the published data,
and including age, duration of severe disease, Jamieson type 3 (J3) CTEPH
lesions, preoperativemean pulmonary arterial pressure, PVR, and PEA sur-
gical timing). As outcome endpoints, we considered the following contin-
uous variables: partial pressure of oxygen in arterial blood/fraction of
inspired oxygen 6 hours after admission to intensive care unit (PaO2/
FiO2 6h) ratio, length of mechanical ventilation (LMV), and total intensive
care unit stay. The following categorical variables were considered: reper-
fusion edema, need for tracheostomy, any infection, transient neurologic
events, operative mortality, and hospital mortality. Also, the PaO2/FiO2
6h ratio, LMV, and total intensive care unit stay were considered when di-
chotomized according to the worst tertile (lower for PaO2/FiO2 6h andss management and cerebral protection strategy
Cerebral protection strategy*
Deep HCA
usion periods Deep HCAwith cNIRS monitoring
usion periods Moderate HCAwith cNIRS monitoring
n periods Moderate HCAwith cNIRS monitoring
darterectomy; cNIRS, cerebral near-infrared spectroscopy. *Pharmacologic protocol
ery c July 2012
TABLE 2. Patient preoperative and operative characteristics
Characteristic Overall Group A Group B Group C Group D
Overall
P value
Significant post hoc
comparisons with Bonferroni
correction: P value< .008
Preoperative
Age (y) 57  16 52  15 56  17 60  15 60  16 <.001 A vs C and D
Age 70 y 95 (27.4) 9 (10.8) 16 (22.9) 31 (34.1) 39 (37.9) <.001 A vs C and D
Male gender 168 (48.4) 47 (56.6) 36 (51.4) 41 (45.1) 44 (42.7) .27 —
LOSD (m)
Median 12 13 17 9 11 .005 B vs C
Interquartile range 6–24 8–24 9–30 5–19 4–24
J3 lesions 93 (26.8) 18 (21.7) 19 (27.1) 24 (26.4) 32 (31.1) .58 —
mPAP (mmHg) 45  13 50  13 46  12 41  12 43  11 <.001 A vs C and D
PVR (dyne $ s $ cm5) 999  482 1214  485 1060  549 877  421 897  419 <.001 A vs C and D
Oxygen therapy 168 (48.4) 39 (47.0) 38 (54.3) 44 (48.4) 47 (45.6) .75 —
Urgent/emergency 76 (21.9) 28 (33.7) 20 (28.6) 13 (14.3) 15 (14.6) .003 A vs C and D
Bilateral PEA 285 (82.1) 66 (79.5) 53 (75.7) 80 (87.9) 86 (83.5) .18 —
Operative
CPB time (min) 308  96 236  77 310  103 333  80 344  87 <.001 A vs B, C, and D
B vs C and D
Hypothermia (C) 21.0  3.4 17.5  1.6 17.9  2.1 23.3  1.9 24.0  0.8 <.001 A vs C and D
B vs C and D
Number of HCA 7.4  5.7 2.0  0.7 3.6  1.5 8.9  3.9 13.1  4.9 <.001 A vs B, C and D
B vs C and D
C vs D
Total HCA time (min) 64.2  39.7 26.4  15.0 50.6  28.9 85.7  36.0 84.9  36.0 <.001 A vs B, C and D
B vs C and D
Data presented as mean  standard deviation, n (%), or median and interquartile range. LOSD, Length of severe disease (World Health Organization class III or IV symptoms);
J3, Jamieson type 3; mPAP, mean pulmonary arterial pressure; PVR, pulmonary vascular resistance; PEA, pulmonary endarterectomy; CPB, cardiopulmonary bypass; HCA,
hypothermic circulatory arrest.
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Dupper for LMV and total intensive care unit stay). Finally, we included
a combined endpoint of none vs any of these endpoints. The absence of
any outcome endpoint was considered uneventful outcome.
Stata, version 11 (StataCorp, College Station, Tex), was used for com-
putation. All P values were 2-sided. Statistical significance was considered
for P<.05. The Bonferroni correction was used for post hoc comparisons.FIGURE 2. Population by group, dichotomized by age. Overall P<.001.
*Significant after Bonferroni correction (P<.008).RESULTS
The patient characteristics were analyzed according to
the 4 groups (Table 2). Over time, the patient age increased
significantly (Figure 2). For the duration of severe disease,
defined as the period from the onset of World Health Orga-
nization class III or IV symptoms, a great variability was
observed. Even if the duration of severe disease assessment
is determined by a patient’s self-evaluation, it is evident that
a late diagnosis remains an important issue.3 CTEPH was
characterized intraoperatively according to Jamieson’s clas-
sification.17 J3 lesions were considered the most challeng-
ing. A trend toward an increase in the number of J3
lesions, even if not statistically significant, reflects our
learning curve. Hemodynamic impairment was more severe
in patients in group A, early in our experience. Urgent PEA
was defined as the need for surgery within 48 hours of the
admission. Emergency PEAwas defined as the need to bring
the patient immediately to the operating room because of
severe hemodynamic instability. A significantly greaterThe Journal of Thoracic and Caproportion of PEAs were performed in urgent or emergency
conditions in group A. This could explain the different pre-
senting hemodynamic profile of the same group and high-
lights the delay in referring patients to surgery early in
our experience. The need for oxygen therapy did not change
over time, confirming that about 50% of patients with oper-
able CTEPH experience chronic respiratory failure.3rdiovascular Surgery c Volume 144, Number 1 103
TABLE 3. Early hemodynamic changes after pulmonary endarterectomy stratified by group
Variable Group A Group B Group C Group D
mPAP (mm Hg)
Preoperative 50  13 46  12 41  12 43  11
Postoperative 27  10 21  8 21  7 23  8
Change 22  12 (20–25) 25  13 (22–28) 20  12 (18–23) 20  13 (17–23)
P value <.001 <.001 <.001 <.001
PVR (dyne $ s $ cm5)
Preoperative 1214  485 1060  549 877  421 897  419
Postoperative 340  239 270  181 276  130 319  202
Change 825  396 (734–916) 758  454 (644–873) 585  427 (487–683) 568  397 (484–653)
P value <.001 <.001 <.001 <.001
Data presented as mean  standard deviation (95% confidence interval). mPAP, Mean pulmonary arterial pressure; PVR, pulmonary vascular resistance.
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changes made to our protocol (Table 2). Hypothermia
changed from 18C (groups A and B) to 24C (groups C
and D). The number of HCA sessions increased signifi-
cantly, as did the total HCA time and, consequently, the
CPB time. Despite the greater number of HCA sessions in
group D than in group C, the total HCA time did not differ,
because each HCA session performed in group D was
shorter.
The hemodynamics at discharge showed a remarkable
improvement in each group (Table 3), with a mean pulmo-
nary arterial pressure reduction of 20 mm Hg or more and
a PVR decrease of more than 560 dyne $ s $ cm5.
The univariate and multivariate outcome analysis results
are summarized in Figure 3 and Table 4. Improved postoper-
ative respiratory function was observed, expressed by
a threefold increase in the likelihood of obtaining a PaO2/
FiO2 6h ratio greater than 217 for group C patients. The in-
troduction of intermittent moderate HCA also resulted in
a significant reduction in the LMV, with a threefold increase
in the likelihood of extubationwithin postoperative day 4 for
group D patients. Furthermore, patients in group D had
a more than threefold decrease in the likelihood of present-
ing with any postoperative infection, perhaps because
ventilator-associated pneumonia is still themost frequent in-
fective complication after PEA.3,6,18,19 Finally, for patients
in groups C and D, a remarkable increase in the likelihood
of having an uneventful outcome was observed, three- to
fourfold, respectively. In concert with the development
of our alternative CPB strategy, a trend toward a reduction
in the incidence of transient neurologic events was
observed. The overall incidence of permanent neurologic
events (6/347) was too low for any comparison. In our
experience, the different CPB strategies influenced neither
operative nor hospital mortality, which were all in line
with previously reported data.3,6,11,17-20
DISCUSSION
A detailed preoperative patient evaluation, appropriate
selection, surgical technique and experience, and104 The Journal of Thoracic and Cardiovascular Surgmeticulous postoperative management are essential pre-
requisites for success after PEA. The selection of pa-
tients for surgery depends on the extent and location
of the organized thrombi in relation to the degree of pul-
monary hypertension. Proximal organized lesions repre-
sent the ideal situation, although the surgical indication
for more distal obstructions can be quite different, ac-
cording to the surgeon’s expertise. The lung ventila-
tion/perfusion scan is still the most sensitive test for
the diagnosis of CTEPH, showing even small ventila-
tion/perfusion mismatches. For operability assessment,
the most powerful diagnostic tool is high-resolution,
64-row angiographic computed tomography, which pro-
vides many useful details about the pulmonary arterial
wall and lumen, heart morphology, lung parenchyma,
and mediastinum.25 The degree of pulmonary hyperten-
sion must be assessed by right heart catheterization,
both at rest and during exercise, to diagnose those pa-
tients with normal hemodynamics at rest but exertional
pulmonary hypertension.
We believe the most relevant challenge in CTEPH re-
mains the diagnosis. Misdiagnosis and late diagnosis lead
to low patient referral and, subsequently, a slow learning
curve. At the beginning of our experience with PEA, our re-
ferral was limited to severely compromised patients, and
about 30% of PEAs were performed as urgent or emer-
gency operations. The referring physicians were reticent
to suggest a surgical evaluation of their elderly patients, be-
cause PEAwas still considered an extremely high-risk oper-
ation. After adopting the intermittent HCA technique as the
procedure of choice, we could safely perform PEA even in
the elderly. As our surgical results were not affected by in-
cluding patients older than 70 years, the referral of the el-
derly to our center increased, reflecting an increased
awareness of the disease and its effective surgical treatment
among the referring physicians. Also, our alternative tech-
nique allowed us to take more time to explore thoroughly
even the segmental branches found to be patent on the an-
giographic computed tomography scan. Some unexpected
lesions such as recanalized thrombi and webs, which canery c July 2012
FIGURE 3. Continuous univariate outcome analysis summarized in box
plot diagrams. PaO2/FiO2 6h, Ratio between partial pressure of oxygen
in arterial blood and fraction of inspired oxygen measured 6 hours after
admission to intensive care unit; LMV, length of mechanical ventilation;
TICUS, total intensive care unit stay. *Significant after Bonferroni correc-
tion (P<.008).
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atively detected and successfully removed. This improved
our collaboration with our radiologist, who created an ar-
chive of the most distal PEA procedures, updated periodi-
cally. During the past 3 years, we have witnessed an
increase in the number of patients referred with CTEPH,
and we have gained experience to extend the surgical indi-
cation to more distal disease. Hemodynamic improvementThe Journal of Thoracic and Caafter PEAwas remarkable for each group, despite a trend to-
ward an increase in the number of J3 lesions.
Although we extended the surgical indication to more
challenging CTEPH,18 and although the patients undergo-
ing PEA were becoming older over time, the outcomes
improved. Our multivariate analysis showed that the intro-
duction of intermittent moderate HCA with periods of 7
minutes at most resulted in improved postoperative respira-
tory function, a reduced LMV, a reduction in the incidence
of infection, and a remarkable improvement in the likeli-
hood of uneventful outcomes.
Retrospective studies are particularly useful in investigat-
ing diseases of low incidence, but any retrospective study is
subject to selection bias. There is no reason to believe that
the epidemiology of CTEPH has changed over time. The in-
crease in the number of patients referred with CTEPH was
rather owing to a recent change in the referring physicians’
attitudes. The intervention, baseline state, and outcomes
were obtained from existing recorded information. How-
ever, our study included all consecutive incident patients.
Our database was not modified over time, and all variables
were collected prospectively. Our case groups were identi-
fied from the same population of operated CTEPH patients.
The groups were noncontemporaneous owing to the study
design. Thus, our learning curve, as well as the changes
made in the patients’ nonoperative management over
time, could not be separated from the sequential changes
in CPB management. However, although some outcome
variables are clearly dependent on the surgeon’s learning
curve, such as the postoperative hemodynamics, other vari-
ables depend most on hypothermia and circulatory arrest, as
neurologic events. In our experience, no differences in the
PVR decrease after PEAwere observed among the 4 groups,
with a postoperative PVR always lower than 350 dyn $ s $
cm5, showing that the surgeon’s learning curve resulted
mainly in the ability to perform PEA for more distal disease.
That this was possible was definitely because of our new
CPB strategy, which resulted in us being able to signifi-
cantly and safely prolong the total HCA time. What
changed in the patients’ outcome after adopting our alterna-
tive technique was the absence of any transient neurologic
event, such as choreic movements, psychomotor agitation,
late awakening, or late extubation due to asthenia. The con-
sequent fast track recovery with early extubation, some-
times even less than 24 hours, resulted in better
postoperative respiratory function, a lower infections rate,
and a remarkable increase in the likelihood of a completely
uneventful outcome. Despite the longer total HCA and CPB
times, operative and hospital mortality were not affected.
We therefore believe that the improvement in patients’ out-
comes mainly resulted from the sequential changes in the
CPBmanagement and cerebral protection strategy, suggest-
ing a protective role for our alternative strategy on the cen-
tral nervous system during surgery.rdiovascular Surgery c Volume 144, Number 1 105
TABLE 4. Categorical univariate and multivariate outcome analysis
Group Patients (n)
Univariate Multivariate*
OR (95% CI) P value Other comparisons OR (95% CI) P value Other comparisons
PaO2/FiO2 6h 217 <.001 .01
A 38 (50.7) 1 1
B 29 (43.3) 0.74 (0.38–1.44) .38 B vs C, P ¼ .004 0.8 (0.39–1.65) .55 B vs C, P ¼ .02
C 19 (21.6) 0.27 (0.14–0.53) <.001 B vs D, P ¼ .01 0.33 (0.15–0.71) .005 B vs D, P ¼ .06
D 25 (24.8) 0.32 (0.17–0.61) <.001 C vs D, P ¼ .61 0.40 (0.19–0.85) .02 C vs D, P ¼ .61
LMV 4 d <.001 .03
A 42 (50.6) 1 1
B 21 (30) 0.42 (0.21–0.82) .01 B vs C, P ¼ .88 0.44 (0.21–0.92) .03 B vs C, P ¼ .37
C 28 (31.1) 0.44 (0.24–0.82) .01 B vs D, P ¼ .21 0.62 (0.3–1.27) .19 B vs D, P ¼ .59
D 22 (21.6) 0.27 (0.14–0.51) <.001 C vs D, P ¼ .14 0.35 (0.17–0.73) .005 C vs D, P ¼ .14
TICUS 7 d .18 .49
A 32 (38.6) 1 1
B 25 (35.7) 0.89 (0.46–1.71) .72 — 0.85 (0.41–1.75) .66 —
C 30 (33) 0.78 (0.42–1.46) .44 — 1.06 (0.52–2.17) .87 —
D 25 (24.3) 0.51 (0.27–0.96) .04 — 0.65 (0.32–1.33) .24 —
Reperfusion edema <.001 .001
A 17 (23) 1 1
B 4 (5.7) 0.21 (0.07–0.65) .007 B vs C, P ¼ .46 0.08 (0.02–0.32) <.001 B vs C, P ¼ .61
C 3 (3.3) 0.12 (0.03–0.41) .001 B vs D, P ¼ .78 0.04 (0.003–0.53) .02 B vs D, P ¼ .15
D 7 (6.9) 0.25 (0.1–0.63) .004 C vs D, P ¼ .28 0.25 (0.07–0.92) .04 C vs D, P ¼ .11
Tracheostomy .84 .88
A 7 (8.4) 1 1
B 4 (5.7) 0.66 (0.18–2.35) .52 — 0.73 (0.18–3.04) .67 —
C 5 (5.5) 0.63 (0.19–2.08) .45 — 0.84 (0.18–3.92) .83 —
D 8 (7.8) 0.91 (0.32–2.64) .87 — 1.22 (0.35–4.23) .75 —
Infections .006 .02
A 18 (21.7) 1 1
B 25 (35.7) 2 (0.98–4.11) .06 B vs C, P ¼ .15 1.9 (0.86–4.17) .11 B vs C, P ¼ .52
C 23 (25.3) 1.22 (0.6–2.47) .58 B vs D, P<.001 1.48 (0.65–3.37) .35 B vs D, P ¼ .004
D 13 (12.5) 0.52 (0.24–1.13) .10 C vs D, P ¼ .02 0.57 (0.24–1.36) .20 C vs D, P ¼ .02
TNE .19 .32
A 13 (17.6) 1 1
B 10 (14.9) 0.82 (0.33–2.03) .67 — 0.81 (0.31–2.13) .67 —
C 9 (10.7) 0.56 (0.23–1.41) .22 — 0.63 (0.24–1.67) .35 —
D 7 (7.1) 0.36 (0.14–0.96) .04 — 0.34 (0.1–1.08) .07 —
Operative mortality .77 .53
A 9 (10.8) 1 1
B 5 (7.1) 0.63 (0.2–1.99) .43 — 0.36 (0.07–1.91) .23 —
C 8 (8.8) 0.79 (0.29–2.16) .65 — 1.26 (0.38–4.1) .71 —
D 7 (6.8) 0.6 (0.21–1.69) .33 — 0.9 (0.29–2.79) .85 —
Hospital mortality .91 .49
A 10 (12.1) 1 1
B 6 (8.6) 0.68 (0.24–1.99) .49 — 0.43 (0.11–1.63) .21 —
C 9 (9.9) 0.80 (0.31–2.08) .65 — 1.17 (0.39–3.51) .78 —
D 10 (9.7) 0.78 (0.31–1.99) .61 — 1.05 (0.38–2.89) .93 —
Uneventful outcome <.001 .001
A 20 (24.1) 1 1
B 22 (31.4) 1.44 (0.71–2.95) .31 B vs C, P ¼ .04 1.39 (0.64–3.02) .41 B vs C, P ¼ .21
C 43 (47.3) 2.82 (1.47–5.41) .002 B vs D, P<.001 2.21 (1.06–4.64) .04 B vs D, P ¼ .003
D 64 (60.4) 4.8 (2.54–9.08) <.001 C vs D, P ¼ .07 4.05 (1.95–8.39) <.001 C vs D, P ¼ .07
OR,Odds ratio;CI, confidence interval; PaO2/FiO2 6h, ratio between partial pressure of oxygen in arterial blood and fraction of inspired oxygen measured 6 hours after admission
to intensive care unit; LMV, length of mechanical ventilation; TICUS, total intensive care unit stay; TNE, transient neurologic event. *Adjusted for age, duration of severe disease
(LOSD), Jamieson type 3 chronic thromboembolic pulmonary hypertension lesions, preoperative mean pulmonary arterial pressure and pulmonary vascular resistance, and pul-
monary endarterectomy surgical timing.
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To achieve a bloodless surgical field to perform a com-
plete PEA, HCA is still considered mandatory. The purpose
of our study was to show the effectiveness of an alternative
CPB management for PEA developed at our center during
a 17-year experience. Our research has shown how our
new technique cannot only reduce the invasiveness of
such demanding surgery, especially for the elderly, but
also extend the surgical indication to patients with exclu-
sively J3 lesions.
In our experience, this new protocol represents an effec-
tive alternative to the original technique, allowing for a bet-
ter combination of surgical accuracy and patient outcomes.
Adopting this strategy, PEA can be performed safely de-
spite a longer total HCA time, thus giving more time for
the accurate dissection of the distal branches. With the com-
bination of moderate hypothermia with intermittent sys-
temic reperfusion, the patient outcomes were improved,
despite treating older patients and more distal disease.
We believe that our described CPBmanagement could be
useful, especially for those centers planning to start a PEA
program, providing the possibility of safely performing sur-
gery with a longer HCA time. This could be particularly
helpful for lung transplant centers, where a PEA program
could maximize the use of scarce organ donors by offering,
when feasible, a nontransplant option to patients with
CTEPH. As an ethical consideration, however, it remains
mandatory to fulfill all the criteria for the definition of an
expert center, as reported in the European guidelines,16 to
offer patients the best treatment and to achieve the best
results.
We would like to express our gratitude to Professor Thomas M.
Egan, MD, MSc, from the University of North Carolina at Chapel
Hill (Chapel Hill, NC) for editorial revision of our report.References
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